Examining The Unified Future of Regulatory Platforms With Astellas
Astellas
Hans van Leeuwen
Head of Regulatory Operations

ArisGlobal is transforming the way today’s most successful life sciences companies develop breakthroughs and bring new products to market. ArisGlobal end-to-end drug development technology platform, LifeSphere®, integrates ArisGlobal proprietary Nava® cognitive computing engine to automate all core functions of the drug development lifecycle. Designed with deep expertise and a long-term perspective that spans more than 30 years, LifeSphere® boosts efficiency, ensures compliance and reduces cost through multi-tenant Software-as-a-Service (SaaS) architecture. Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China.
Showing 13 ArisGlobal Customer Success Stories
Astellas
Hans van Leeuwen
Head of Regulatory Operations
Bio-Pharma Company
Blueprint Medicines
Anand Ananthakrishnan
Senior Director of Drug Safety and Pharmacovigilance
Contract Research Organization
Fujirebio Diagnostics
Rachel Radwan
Director of Clinical R&D
Global CRO Pharmaceutical and Biotech Industry
Global Pharma Company
International Pharmaceutical Company
Large Multinational Medical Device and Health Care Organization
Mid-Tier Biotechnology Company
PPD
Cindy Elko-Simms
Vice President, Pharmacovigilance
Syngene International
Anand Eswaraiah
Head of Biometrics, Medical and Regulatory Affairs
Total Clinical Trial Management
Paige Queen
Senior Director of Clinical Operations
No matching case studies